Ryan Specialty (NYSE:RYAN – Get Free Report) had its target price increased by stock analysts at UBS Group from $82.00 to $84.00 in a report released on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. UBS Group’s target price suggests a potential upside of 22.33% from the company’s current price.
Several other equities analysts have also recently issued reports on RYAN. Wells Fargo & Company boosted their price objective on shares of Ryan Specialty from $64.00 to $69.00 and gave the company an “equal weight” rating in a research note on Friday, February 21st. Morgan Stanley began coverage on Ryan Specialty in a report on Thursday, December 5th. They issued an “overweight” rating and a $90.00 price target for the company. Keefe, Bruyette & Woods dropped their price objective on Ryan Specialty from $77.00 to $76.00 and set an “outperform” rating on the stock in a report on Friday, February 21st. Barclays raised their target price on Ryan Specialty from $76.00 to $88.00 and gave the company an “overweight” rating in a report on Thursday, November 21st. Finally, Royal Bank of Canada lowered their price target on shares of Ryan Specialty from $73.00 to $72.00 and set a “sector perform” rating on the stock in a research note on Friday, February 21st. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Ryan Specialty presently has a consensus rating of “Hold” and a consensus price target of $75.27.
Get Our Latest Analysis on RYAN
Ryan Specialty Trading Down 0.5 %
Ryan Specialty (NYSE:RYAN – Get Free Report) last posted its quarterly earnings results on Thursday, February 20th. The company reported $0.45 EPS for the quarter, missing the consensus estimate of $0.47 by ($0.02). The business had revenue of $663.53 million during the quarter, compared to analyst estimates of $658.80 million. Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. As a group, sell-side analysts forecast that Ryan Specialty will post 2.29 EPS for the current fiscal year.
Insiders Place Their Bets
In related news, Director Nicholas Dominic Cortezi sold 35,000 shares of the stock in a transaction dated Friday, December 13th. The shares were sold at an average price of $67.39, for a total transaction of $2,358,650.00. Following the completion of the sale, the director now owns 65,100 shares in the company, valued at $4,387,089. This trade represents a 34.97 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders sold a total of 316,451 shares of company stock worth $20,907,793 over the last quarter. Company insiders own 11.10% of the company’s stock.
Institutional Inflows and Outflows
A number of large investors have recently added to or reduced their stakes in RYAN. Hollencrest Capital Management bought a new stake in Ryan Specialty in the 3rd quarter valued at $25,000. Rakuten Securities Inc. acquired a new stake in Ryan Specialty during the 4th quarter worth approximately $27,000. Assetmark Inc. bought a new position in Ryan Specialty during the 3rd quarter worth $34,000. Kapitalo Investimentos Ltda acquired a new stake in shares of Ryan Specialty during the 4th quarter worth approximately $36,000. Finally, Principal Securities Inc. lifted its position in shares of Ryan Specialty by 164.7% during the 4th quarter. Principal Securities Inc. now owns 667 shares of the company’s stock worth $43,000 after buying an additional 415 shares during the last quarter. 84.82% of the stock is currently owned by institutional investors and hedge funds.
About Ryan Specialty
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
See Also
- Five stocks we like better than Ryan Specialty
- How to Buy Cheap Stocks Step by Step
- Buffett’s on the Sidelines – Should You Follow?
- The Significance of Brokerage Rankings in Stock Selection
- AST SpaceMobile Stock Surges 17% After Analyst Upgrade
- 3 Dividend Kings To Consider
- 3 Stocks With Triple-Digit PEs That Are Still Worth a Look
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.